Skip to main content
OpenTrials

Clinical trial condition

Cervical Squamous Cell Carcinoma

Explore clinical trials studying Cervical Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

39 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Cervical Squamous Cell Carcinoma trial results

Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

NCT07217171

Conditions
Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +38 more
Locations
  • City of Hope Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
  • The Winship Cancer Institute Emory University Atlanta, Georgia, United States
View all 15 locations
View Trial Details
Recruiting

External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer

NCT06543576

Conditions
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, +1 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • University of California San Diego (UCSD) San Diego, California, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
  • University of Virginia Cancer Center Charlottesville, Virginia, United States
View Trial Details
Recruiting

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

NCT07169734

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Transitional Cell, +19 more
Locations
  • Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale Comprehensive Cancer Center New Haven, Connecticut, United States
  • The University of Chicago Medical Center - Oncology Chicago, Illinois, United States
View all 41 locations
View Trial Details
Recruiting

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

NCT06747585

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cervical Squamous Cell Carcinoma, +16 more
Locations
  • Mayo Foundation for Medical Education and Research - Mayo Cl Scottsdale, Arizona, United States
  • Providence Medical Foundation Fullerton, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale Comprehensive Cancer Center New Haven, Connecticut, United States
View all 41 locations
View Trial Details
Recruiting

A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers

NCT05910827

Conditions
Advanced Cutaneous Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +21 more
Locations
  • GenesisCare North Shore Sydney, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • ICON Cancer Centre South Brisbane Brisbane, Queensland, Australia
  • Greenslopes Private Hospital Greenslopes, Queensland, Australia
View all 20 locations
View Trial Details
Active, not recruiting

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

NCT02466971

Conditions
Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma, Advanced Vaginal Squamous Cell Carcinoma, +33 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 381 locations
View Trial Details
Active, not recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations
  • Shalby Hospital Ahmedabad, Gujarat, India
  • National Cancer Institute Jhajjar, Haryana, India
  • All India Institute of Medical Sciences New Delhi, India
  • PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India
View Trial Details
Active, not recruiting

Primary Cervical Cancer Screening by Self-sampling HPV Test

NCT05613283

Conditions
Adenocarcinoma, Adenocarcinoma in Situ, Atypical Glandular Cells, +48 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The Third Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
  • Hunan Provincial Maternal and Child Health Care Hospital Changsha, Hunan, China
View Trial Details

Related conditions